Progression-free and overall survival in metastatic castration-resistant prostate cancer treated with abiraterone acetate can be predicted with serial C11-acetate PET/CT.
about
Progression-free and overall survival in metastatic castration-resistant prostate cancer treated with abiraterone acetate can be predicted with serial C11-acetate PET/CT.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Progression-free and overall s ...... ith serial C11-acetate PET/CT.
@en
type
label
Progression-free and overall s ...... ith serial C11-acetate PET/CT.
@en
prefLabel
Progression-free and overall s ...... ith serial C11-acetate PET/CT.
@en
P2093
P2860
P1433
P1476
Progression-free and overall s ...... ith serial C11-acetate PET/CT.
@en
P2093
Agnes Wadelius
Anders Ullén
Hans Jacobsson
Jacob Farnebo
Lennart Blomqvist
Per Sandström
Sten Nilsson
P2860
P356
10.1097/MD.0000000000004308
P407
P577
2016-08-01T00:00:00Z